Erasca Inc (ERAS): Next-Year EPS Estimate 41.32%
As of 2026-06-04, Erasca Inc (ERAS) has a next-year EPS growth estimate of 41.32%.
On 2026-06-04, analyst consensus for ERAS's next-year EPS growth shifted from 41.53% to 41.32% — a negative change of 0.21 percentage points. Current-year growth is projected at -118.32%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 41.32%
- EPS growth this year
- -118.32%
- EPS next quarter (est)
- -$0.11
- Last price
- $13.27
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 41.32% | -118.32% | -$0.11 | $13.27 |
| 2026-06-03 | 41.53% | -118.32% | -$0.11 | $13.18 |
| 2026-06-02 | 41.53% | -118.32% | -$0.11 | $13.48 |
| 2026-06-01 | 41.53% | -118.32% | -$0.11 | $13.82 |
| 2026-05-31 | 41.53% | -118.32% | -$0.11 | $12.84 |
| 2026-05-28 | 41.53% | -118.32% | -$0.11 | $12.20 |
| 2026-05-27 | 41.53% | -118.32% | -$0.11 | $12.47 |
| 2026-05-26 | 41.53% | -118.32% | -$0.11 | $11.50 |
| 2026-05-25 | 41.53% | -118.32% | -$0.11 | $11.24 |
| 2026-05-24 | 41.53% | -118.32% | -$0.11 | $11.24 |
| 2026-05-21 | 41.53% | -118.32% | -$0.11 | $11.60 |
| 2026-05-20 | 41.53% | -118.32% | -$0.11 | $11.12 |
| 2026-05-19 | 41.53% | -118.32% | -$0.11 | $10.32 |
| 2026-05-18 | 41.53% | -118.32% | -$0.11 | $10.27 |
| 2026-05-17 | 41.53% | -118.32% | -$0.11 | $10.23 |
| 2026-05-14 | 41.53% | -118.32% | -$0.11 | $10.37 |
| 2026-05-13 | 38.27% | -104.93% | -$0.11 | $10.39 |
| 2026-05-12 | 34.60% | -91.20% | -$0.11 | $10.38 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Erasca Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Erasca Inc (ERAS) has a next-year EPS growth estimate of 41.32%, based on analyst consensus.
When was the latest EPS estimate revision for ERAS?▾
The most recent revision occurred on 2026-06-04, when analysts adjusted the next-year EPS growth estimate from 41.53% to 41.32%.
What sector and industry does Erasca Inc belong to?▾
Erasca Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ERAS appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Erasca Inc (ERAS) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports